Augmedix(US:AUGX)2023-03-27 11:37Company Overview - Augmedix offers real-time and asynchronous virtual medical documentation for clinicians, connecting them with the Notebuilder Platform through mobile devices and proprietary software[9] - The company serves over 20 health systems[9] - Augmedix's solutions can save clinicians up to 3 hours per day, boost productivity by as much as 20%, and improve work-life satisfaction by 40%[8] - Augmedix has a large addressable market, with approximately 295,000 clinicians in the U S [14] Financial Performance - Augmedix achieved $8 8 million in Q4 2022 revenue, representing a 126% year-over-year net revenue retention[9] - The company's revenue for 2022 was $30 9 million, compared to $22 2 million in 2021, indicating a 40% year-over-year growth[9] Market Opportunity and Strategy - Augmedix estimates a $6 billion U S market opportunity[14] - The company sees a $1B+ expansion opportunity within existing customers[14] - The company's strategy involves moving from point solution sales to portfolio sales, with a focus on EHR integration to enable hyper-scaling[17] Technology and Solutions - Augmedix uses a building block approach that combines automated speech recognition, natural language processing, large language models, and clinical datasets[22] - The company's Notebuilder Platform uses Natural Language Processing (NLP) and Large Language Models (LLMs) to enhance documentation[12]